Detection and Management of Intraocular Inflammation after Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration

被引：0
|
作者：
Bodaghi, Bahram
Souied, Eric H.
Tadayoni, Ramin
Weber, Michel
Ponthieux, Anne
Kodjikian, Laurent
机构：
来源：
OPHTHALMOLOGY | 2023年 / 130卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1106 / 1106
页数：1
相关论文
共 50 条
  • [41] Advances in the treatment of neovascular age-related macular degeneration
    Lanzetta, Paolo
    EJHP PRACTICE, 2008, 14 (06): : 17 - 20
  • [42] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Bae, Ki Woong
    Kim, Dong Ik
    Hwang, Daniel Duck-Jin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [43] A case of recalcitrant neovascular wet age-related macular degeneration treated with Intravitreal Brolucizumab
    Panigrahi, Pradeep Kumar
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [44] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2022, 119 (03): : 258 - 264
  • [45] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Ki Woong Bae
    Dong Ik Kim
    Daniel Duck-Jin Hwang
    Scientific Reports, 12
  • [46] Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
    Hussain, Rehan M.
    Neal, Andrea
    Yannuzzi, Nicolas A.
    Patel, Kevin H.
    Huo, Siya
    Hariprasad, Seenu M.
    Bhatia, Sumit P.
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [47] Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
    Dugel, Pravin U.
    Jaffe, Glenn J.
    Sallstig, Peter
    Warburton, James
    Weichselberger, Andreas
    Wieland, Mark
    Singerman, Lawrence
    OPHTHALMOLOGY, 2017, 124 (09) : 1296 - 1304
  • [48] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGIE, 2022, 119 (03): : 258 - 264
  • [49] EFFECT OF INTRAOCULAR PRESSURE-LOWERING MEDICATIONS ON NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATMENT OUTCOMES IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENT TRIALS
    Rahimy, Ehsan
    Ying, Gui-Shuang
    Pan, Wei
    Hsu, Jason
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (04): : 636 - 647
  • [50] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
12345